VDR and prostate cancer: A recent meta-analysis, including thirty-four studies for a total of 10,267 cases and 11,489 controls, focused on the association between vitamin D receptor (VDR) polymorphisms, which mediate the cellular effects of vitamin D and risk of prostate cancer.